Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366742 · ClinicalTrials.gov registry record
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
A clinical trial of Human Papilloma Virus and CIN 2, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 900
- Enrollment target
- 2
- Study locations
NCT01366742: Completed study of Human Papilloma Virus and CIN 2, sponsored by University of California, Los Angeles.
NCT01366742 is a study of Human Papilloma Virus and CIN 2 that has completed, run by University of California, Los Angeles. The registered enrollment target is 900 participants, below the 8,418-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01366742, a study of Human Papilloma Virus and CIN 2, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
- 2
- Study locations
Study Summary
The natural history of human papillomavirus (HPV) is most likely influenced by both innate and adaptive mucosal immunity. More specifically, we hypothesize that Toll like receptors (TLR) play an important role in cervical innate immunity to HPV through secretions of proinflammatory, chemotactic and anti-viral cytokines. Up-regulated TLR expression will also result in activation of dendritic cells and T cells that in turn will promote a T helper (Th) l like response through secretion of several cytokines and consequently, the induction of a successful cell mediated immune (CMI) response.
Primary Outcome
Observational study of women with HPV
Conditions Studied
Study Locations (2)
California
- SFSU Student Health Center - San Francisco
- HPV Study - San Leandro Office - San Leandro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 1987-12 |
| Est. Completion | 2016-05 |
What the finished NCT01366742 record still lists
NCT01366742 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 8,418-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 0 interventions.
NCT01366742 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01366742 about?
NCT01366742 is a clinical study titled "Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women". The natural history of human papillomavirus (HPV) is most likely influenced by both innate and adaptive mucosal immunity. More specifically, we hypothesize that Toll like receptors (TLR) play an important role in cervical innate immunity to HPV through secretions of proinflammatory, chemotactic and ...
What is the current status of trial NCT01366742?
This trial is currently completed. The enrollment target is 900 participants. The study started on 1987-12. Estimated completion is 2016-05.
What conditions does trial NCT01366742 study?
This clinical trial studies the following conditions: Human Papilloma Virus, CIN 2, CIN 3.
Who is sponsoring clinical trial NCT01366742?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01366742 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01366742's enrollment target sits among peer trials
900 10th of 39 higher than 30 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia